Status:
COMPLETED
Exploring Efficacy, Cost Effectiveness and Experiences Related to Adherence of Different Bisphosphonate Regimens for the Prevention of Osteoporotic Fragility Fractures.
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Collaborating Sponsors:
University of Nottingham
Conditions:
Osteoporosis
Eligibility:
All Genders
18+ years
Brief Summary
Osteoporosis is a condition where bones become weak and fragile and can easily break. Suffering from one fragility fracture doubles your chance of having another. These fractures can affect a person's...
Detailed Description
This information provided relates to Stage 1B. Stage 1A does not involve participants. Stage 2 will be conducted by the Royal Osteoporosis Society. Participants will not be invited via NHS (National H...
Eligibility Criteria
Inclusion
- Adults over the age of 18 with the ability to give informed consent and represent one of the following stakeholder groups:
- GPs
- Patients who started on oral bisphosphonates within the last 24 months for prevention of fragility fractures
- Secondary care specialist clinicians (nurses, consultants) involved in the treatment of osteoporosis.
- Patients receiving hospital based (intravenous) bisphosphonate treatments for prevention of fragility fractures who began treatment within the last 24 months
- Clinical academics involved in osteoporosis research
- Specialist clinicians (nurses, consultants) from the osteoporosis service in Nottingham and Sheffield with insight into alternate bisphosphonate treatments
- Patients receiving alternate bisphosphonate treatments for prevention of fragility fractures who began treatment within the last 24 months
- Commissioners involved in osteoporosis services
Exclusion
- Patients who take bisphosphonate medicines for reasons other than osteoporosis or osteopenia, including patients with an active cancer, primary hyperparathyroidism and Paget's disease.
- Are unable to give informed consent
- Considered to be near to end of life.
Key Trial Info
Start Date :
March 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04283786
Start Date
March 6 2020
End Date
May 31 2022
Last Update
April 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nottingham University Hospitals Trust, Queens Medical Centre
Nottingham, Nottinghamshire, United Kingdom, NG7 2UH